Celsius Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Results on Thursday, Feb. 29, 2024
Celsius Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Results on Thursday, Feb. 29, 2024
PR Newswire
BOCA RATON, Fla., Feb. 22, 2024
BOCA RATON, Fla., Feb. 22, 2024 /PRNewswire/ -- Celsius Holdings, Inc. (Nasdaq: CELH) will release its fourth quarter and full year 2023 financial results on Thursday, Feb. 29, 2024, before markets open. Following the release, management will host a conference call at 10 a.m. ET, to discuss the financial results and lead a question-and-answer session.
Participants may join the conference call by dialing 877-709-8150 (domestic) or +1 201-689-8354 (international). Alternatively, participants may join using the webcast link https://event.choruscall.com/mediaframe/webcast.html?webcastid=gvxb9rgY.
An audio replay of the call will be available for six months through the webcast link above after the event.
About Celsius Holdings, Inc.
Celsius Holdings, Inc. (Nasdaq: CELH) is the maker of energy drink brand CELSIUS®, a lifestyle energy drink born in fitness and a pioneer in the rapidly growing energy category. For more information, please visit www.celsiusholdings.com.
Investor Contact:
Paul Wiseman
investorrelations@celsius.com
Press Contact:
press@celsius.com
SOURCE Celsius Holdings, Inc.
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track